NCT02338622View on ClinicalTrials.gov

Trial of Olaparib in Combination with AZD5363 (ComPAKT)

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 21, 2016

Study Completion Date

March 21, 2017

Conditions
Advanced Cancer
Interventions
DRUG

olaparib

olaparib BD

DRUG

AZD5363

AZD5363 BD

Trial Locations (2)

NE7 7DN

Northern Institute for Cancer, Freeman Hospital, Newcastle

SM2 5PT

Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Royal Marsden NHS Foundation Trust

OTHER